George Fennell

CIK: 0001521861

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)9 (29.0%)

Position reduction

Option Exercises (M)13 (41.9%)

Derivative conversions

Awards (A)6 (19.4%)

Compensation grants

Other (G, F, J, C, D, …)3 (9.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IDXX

IDEXX LABORATORIES INC /DE

Officer

Discretionary Trading P&L

Holdings

Transaction History (31 total)

IDXX
IDEXX LABORATORIES INC /DE
Jun 1, 2026
Tax Payment(F)
Direct
284 shares at avg. $566.79$161K
IDXX
IDEXX LABORATORIES INC /DE
Jun 1, 2026
Exercise(M)
Direct
639 shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 14, 2026
Tax Payment(F)
Direct
199 shares at avg. $629.35$125K
IDXX
IDEXX LABORATORIES INC /DE
Feb 14, 2026
Exercise(M)
Direct
56 shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 14, 2026
Exercise(M)
Direct
139 shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 14, 2026
Exercise(M)
Direct
204 shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 14, 2026
Exercise(M)
Direct
55 shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 12, 2026
Award(A)
Non-Qualified Stock Option (right-to-buy)
Direct
3.4K shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 12, 2026
Award(A)
Incentive Stock Option (right-to-buy)
Direct
162 shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 12, 2026
Award(A)
Restricted Stock Unit
Direct
810 shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 10, 2026
Sale(S)
Direct
1.1K shares at avg. $643.00$727K
IDXX
IDEXX LABORATORIES INC /DE
Feb 10, 2026
Exercise(M)
Direct
11.3K shares at avg. $67.85$770K
IDXX
IDEXX LABORATORIES INC /DE
Feb 10, 2026
Sale(S)
Direct
397 shares at avg. $644.02$256K
IDXX
IDEXX LABORATORIES INC /DE
Feb 10, 2026
Sale(S)
Direct
2.2K shares at avg. $645.25$1.4M
IDXX
IDEXX LABORATORIES INC /DE
Feb 10, 2026
Sale(S)
Direct
2.8K shares at avg. $646.23$1.8M
IDXX
IDEXX LABORATORIES INC /DE
Feb 10, 2026
Sale(S)
Direct
1.1K shares at avg. $647.21$686K
IDXX
IDEXX LABORATORIES INC /DE
Feb 10, 2026
Sale(S)
Direct
966 shares at avg. $648.78$627K
IDXX
IDEXX LABORATORIES INC /DE
Feb 10, 2026
Sale(S)
Direct
2.8K shares at avg. $649.26$1.8M
IDXX
IDEXX LABORATORIES INC /DE
Feb 10, 2026
Sale(S)
Direct
40 shares at avg. $650.32$26K
IDXX
IDEXX LABORATORIES INC /DE
Feb 9, 2026
Exercise(M)
Direct
1.5K shares at avg. $67.85$100K
IDXX
IDEXX LABORATORIES INC /DE
Feb 14, 2025
Exercise(M)
Direct
140 shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 14, 2025
Exercise(M)
Direct
57 shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 14, 2025
Exercise(M)
Direct
56 shares-
IDXX
IDEXX LABORATORIES INC /DE
Feb 14, 2025
Tax Payment(F)
Direct
133 shares at avg. $444.53$59K
IDXX
IDEXX LABORATORIES INC /DE
Feb 14, 2025
Exercise(M)
Direct
51 shares-

		Type	Shares	Price		Ownership
Jun 1, 2026	IDXX IDEXX LABORATORIES INC /DE	Tax Payment(F)	284	$566.79	$160,968	Direct
Jun 1, 2026	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	639	-	$0	Direct
Feb 14, 2026	IDXX IDEXX LABORATORIES INC /DE	Tax Payment(F)	199	$629.35	$125,241	Direct
Feb 14, 2026	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	56	-	$0	Direct
Feb 14, 2026	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	139	-	$0	Direct
Feb 14, 2026	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	204	-	$0	Direct
Feb 14, 2026	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	55	-	$0	Direct
Feb 12, 2026	IDXX IDEXX LABORATORIES INC /DE	Award(A) Non-Qualified Stock Option (right-to-buy)	3,384	-	-	Direct
Feb 12, 2026	IDXX IDEXX LABORATORIES INC /DE	Award(A) Incentive Stock Option (right-to-buy)	162	-	-	Direct
Feb 12, 2026	IDXX IDEXX LABORATORIES INC /DE	Award(A) Restricted Stock Unit	810	-	-	Direct
Feb 10, 2026	IDXX IDEXX LABORATORIES INC /DE	Sale(S)	1,130	$643.00	$726,587	Direct
Feb 10, 2026	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	11,345	$67.85	$769,758	Direct
Feb 10, 2026	IDXX IDEXX LABORATORIES INC /DE	Sale(S)	397	$644.02	$255,674	Direct
Feb 10, 2026	IDXX IDEXX LABORATORIES INC /DE	Sale(S)	2,161	$645.25	$1,394,388	Direct
Feb 10, 2026	IDXX IDEXX LABORATORIES INC /DE	Sale(S)	2,782	$646.23	$1,797,800	Direct
Feb 10, 2026	IDXX IDEXX LABORATORIES INC /DE	Sale(S)	1,060	$647.21	$686,039	Direct
Feb 10, 2026	IDXX IDEXX LABORATORIES INC /DE	Sale(S)	966	$648.78	$626,721	Direct
Feb 10, 2026	IDXX IDEXX LABORATORIES INC /DE	Sale(S)	2,809	$649.26	$1,823,771	Direct
Feb 10, 2026	IDXX IDEXX LABORATORIES INC /DE	Sale(S)	40	$650.32	$26,013	Direct
Feb 9, 2026	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	1,476	$67.85	$100,147	Direct
Feb 14, 2025	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	140	-	-	Direct
Feb 14, 2025	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	57	-	-	Direct
Feb 14, 2025	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	56	-	-	Direct
Feb 14, 2025	IDXX IDEXX LABORATORIES INC /DE	Tax Payment(F)	133	$444.53	$59,122	Direct
Feb 14, 2025	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	51	-	-	Direct

1-25 of 31 transactions

About FENNELL GEORGE

FENNELL GEORGE (SEC CIK 0001521861) files insider reports with the SEC as Executive Vice President of IDEXX LABORATORIES INC /DE (IDXX).

Signal8 holds 5 ownership filings by FENNELL GEORGE, all Form 4s, filed between Feb 11, 2025 and Jun 2, 2026. Those filings report 31 transactions, from Feb 7, 2025 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on FENNELL GEORGE's filings is in WESTBROOK, ME.

Recent filings by FENNELL GEORGE

Jun 1, 2026: Tax withholding of IDXX shares (Form 4, code F).
Jun 1, 2026: Option exercise of IDXX shares (Form 4, code M).
Feb 14, 2026: Tax withholding of IDXX shares (Form 4, code F).
Feb 14, 2026: Option exercises of IDXX shares (4 lines, Form 4, code M).
Feb 12, 2026: Grants or awards of IDXX derivative securities (3 lines, Form 4, code A).

Other insiders filing for IDEXX LABORATORIES INC /DE (IDXX)

HOOLEY JOSEPH L, Director
Kingsley Lawrence D, Director
Emerson Andrew, EVP, CFO and Treasurer
Vandebroek Sophie V., Director
SAMAD SAM, Director
Peacock Karen, Director

How to read Form 4 transaction codes